Discover how inflammation biomarkers in blood tests are revolutionizing lung cancer prognosis and treatment prediction.
Exploring the silent degradation of antigens in stored paraffin tissue blocks and scientific solutions to preserve critical biomarkers for medical research.
Explore how pharmacodynamic markers help scientists track perifosine's efficacy as a targeted cancer therapy targeting the Akt protein in the PI3K/Akt/mTOR pathway.
Breakthrough research on CD45−/CD31+/CD105+ circulating cells as potential biomarkers for gynecologic malignancies including ovarian, cervical, and endometrial cancers.
How a hierarchical machine learning approach is discovering precise biomarkers in prostate cancer, bringing us closer to the era of personalized medicine.
Discover how molecular biomarkers are transforming the diagnosis and treatment of perinatal asphyxia, offering new hope for protecting newborns' neurological development.
Explore how statistical approaches and biomarker research are revolutionizing melanoma prognosis and personalized treatment approaches.
Discover how opium use creates distinct biological signatures that increase cancer risk through IL-33/sST2 imbalance and adiponectin receptor changes.
Discover how MALDI-TOF MS enables high-throughput quantitative analysis of N-glycans, revealing the sugary fingerprints on cells and opening new frontiers in medicine.
Discover how the 1990s shifted health strategies from reactive treatment to proactive prediction through biomarkers, changing preventive medicine forever.